C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61P 7/02 (2006.01) A61P 9/00 (2006.01)
Patent
CA 2668182
The present invention is directed to novel bicyclic triazolopyrimidine compounds of Formula (I) or a form thereof, wherein X1, X2, R1 R2, R3 and R4 are as defined herein, and their methods of preparation and use as ADP inhibitors.
La présente invention concerne de nouveaux composés bicycliques de la triazolopyrimidine représentés par la formule (I) ou l'une de ses formes. Dans cette formule, X1, X2, R1 R2, R3 et R4 sont tels que définis dans la description. L'invention concerne également les procédés d'élaboration correspondants et leur utilisation comme inhibiteur de l'adénosine 5'-diphosphate (ADP).
Chen Cailin
Maryanoff Bruce E.
Ye Hong
Zhang Han-Cheng
Janssen Pharmaceutica N.v.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Triazolopyrimidine derivatives as adp p2y12 receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazolopyrimidine derivatives as adp p2y12 receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolopyrimidine derivatives as adp p2y12 receptor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1532696